|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 112, Issue 19 3205-3213, Copyright © 1999 by Company of Biologists
JOURNAL ARTICLES |
L Masiero, KA Lapidos, I Ambudkar and EC Kohn
Molecular Signaling Section, Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 20892, USA.
We have shown that nonvoltage-operated Ca(2+) entry regulates human umbilical vein endothelial cell adhesion, migration, and proliferation on type IV collagen. We now demonstrate a requirement for Ca(2+) influx for activation of the RhoA pathway during endothelial cell spreading on type IV collagen. Reorganization of actin into stress fibers was complete when the cells where fully spread at 90 minutes. No actin organization into stress fibers was seen in endothelial cells plated on type I collagen, indicating a permissive effect of type IV collagen. CAI, a blocker of nonvoltage-operated Ca(2+) channels, prevented development of stress fiber formation in endothelial cells on type IV collagen. This permissive effect was augmented by Ca(2+) influx, as stimulated by 0. 5 microM thapsigargin or 0.1 microM ionomycin, yielding faster development of actin stress fibers. Ca(2+) influx and actin rearrangement in response to thapsigargin and ionomycin were abrogated by CAI. Activated, membrane-bound RhoA is a substrate for C3 exoenzyme which ADP-ribosylates and inactivates RhoA, preventing actin stress fiber formation. Pretreatment of endothelial cells with C3 exoenzyme prevented basal and thapsigargin-augmented stress fiber formation. While regulation of Ca(2+) influx did not alter RhoA translocation, it reduced in vitro ADP-ribosylation of RhoA (P(2)<0. 05), suggesting Ca(2+) influx is needed for RhoA activation during spreading on type IV collagen; no Ca(2+) regulated change in RhoA was seen in HUVECs spreading on type I collagen matrix. Blockade of Ca(2+) influx of HUVEC spread on type IV collagen also reduced tyrosine phosphorylation of p190Rho-GAP and blocked thapsigargin-enhanced binding of p190Rho-GAP to focal adhesion kinase. Thus, Ca(2+) influx is necessary for RhoA activation and for linkage of the RhoA/stress fiber cascade to the focal adhesion/focal adhesion kinase pathway during human umbilical vein endothelial cell spreading on type IV collagen.
This article has been cited by other articles:
|
|
 |
|
  M. Xu, C. L. Waters, C. Hu, R. B. Wysolmerski, P. A. Vincent, and F. L. Minnear Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase Am J Physiol Cell Physiol, October 1, 2007; 293(4): C1309 - C1318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Holinstat, N. Knezevic, M. Broman, A. M. Samarel, A. B. Malik, and D. Mehta Suppression of RhoA Activity by Focal Adhesion Kinase-induced Activation of p190RhoGAP: ROLE IN REGULATION OF ENDOTHELIAL PERMEABILITY J. Biol. Chem., January 27, 2006; 281(4): 2296 - 2305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. P. Kole, Y. Tseng, L. Huang, J. L. Katz, and D. Wirtz Rho Kinase Regulates the Intracellular Micromechanical Response of Adherent Cells to Rho Activation Mol. Biol. Cell, July 1, 2004; 15(7): 3475 - 3484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.-P. Zheng, A. M. Sieuwerts, T. M. Luider, M. van der Weiden, P. A.E. Sillevis-Smitt, and J. M. Kros Differential Expression of Splicing Variants of the Human Caldesmon Gene (CALD1) in Glioma Neovascularization versus Normal Brain Microvasculature Am. J. Pathol., June 1, 2004; 164(6): 2217 - 2228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Hussain, H. Kotz, L. Minasian, A. Premkumar, G. Sarosy, E. Reed, S. Zhai, S. M. Steinberg, M. Raggio, V. K. Oliver, et al. Phase II Trial of Carboxyamidotriazole in Patients With Relapsed Epithelial Ovarian Cancer J. Clin. Oncol., December 1, 2003; 21(23): 4356 - 4363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. SOMLYO and A. V. SOMLYO Ca2+ Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase Physiol Rev, October 1, 2003; 83(4): 1325 - 1358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Heneweer, L. H. Kruse, F. Kindhauser, M. Schmidt, K. H. Jakobs, H.-W. Denker, and M. Thie Adhesiveness of human uterine epithelial RL95-2 cells to trophoblast: Rho protein regulation Mol. Hum. Reprod., November 1, 2002; 8(11): 1014 - 1022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Carter, M. Begaye, and N. L. Kanagy Acute and chronic NOS inhibition enhances alpha 2- adrenoreceptor-stimulated RhoA and Rho kinase in rat aorta Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1361 - H1369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Grove, V. V. Prabhu, B. L. Young, F. C. Lee, V. Kulpa, P. J. Munson, and E. C. Kohn Both Protein Activation and Gene Expression Are Involved in Early Vascular Tube Formation in Vitro Clin. Cancer Res., September 1, 2002; 8(9): 3019 - 3026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. T. Arthur and K. Burridge RhoA Inactivation by p190RhoGAP Regulates Cell Spreading and Migration by Promoting Membrane Protrusion and Polarity Mol. Biol. Cell, September 1, 2001; 12(9): 2711 - 2720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kimura, M. Oike, T. Koyama, and Y. Ito Alterations of Ca2+ mobilizing properties in migrating endothelial cells Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H745 - H754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Kohn, E. Reed, G. A. Sarosy, L. Minasian, K. S. Bauer, F. Bostick-Bruton, V. Kulpa, E. Fuse, A. Tompkins, M. Noone, et al. A Phase I Trial of Carboxyamido-triazole and Paclitaxel for Relapsed Solid Tumors: Potential Efficacy of the Combination and Demonstration of Pharmacokinetic Interaction Clin. Cancer Res., June 1, 2001; 7(6): 1600 - 1609. [Abstract] [Full Text] [PDF]
|
|
